Thomas Radtke, Milo A. Puhan, Helge Hebestreit, Susi Kriemler 

Slides:



Advertisements
Similar presentations
Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis  Giuseppe Valenza, Dennis Tappe, Doris.
Advertisements

ARFI and transient elastography for characterization of cystic fibrosis related liver disease: First longitudinal follow-up data in adult patients  Thomas.
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Effects of ivacaftor on severely ill patients with cystic fibrosis carrying a G551D mutation  Helge Hebestreit, Annette Sauer-Heilborn, Rainald Fischer,
The prevalence of “risky behaviour” in adults with cystic fibrosis
Treatment compliance in children and adults with Cystic Fibrosis
Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus  Magnus Hillman, Leif Eriksson, Lena Mared, Karin Helgesson,
Is infection with hypermutable Pseudomonas aeruginosa clinically significant?  Adi Auerbach, Eitan Kerem, Marc Victor Assous, Elie Picard, Maskit Bar-Meir 
R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J
ARFI and transient elastography for characterization of cystic fibrosis related liver disease: First longitudinal follow-up data in adult patients  Thomas.
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
Avani C. Modi, Crystal S. Lim, Nami Yu, David Geller, Mary H
Scott D. Sagel, Marci K. Sontag, Meg M
Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Cirrhosis and other liver disease in cystic fibrosis
Stigma and optimism in adolescents and young adults with cystic fibrosis  Kendea N. Oliver, Matthew L. Free, Cody Bok, Karen S. McCoy, Kathleen L. Lemanek,
The ease of breathing test tracks clinical changes in cystic fibrosis
Rate of improvement of CF life expectancy exceeds that of general population— Observational death registration study  Matthew N. Hurley, Tricia M. McKeever,
Delayed publication of clinical trials in cystic fibrosis
The application of current lifetable methods to compare cystic fibrosis median survival internationally is limited  Abaigeal D. Jackson, Leslie Daly,
Controlled clinical trials in cystic fibrosis — are we doing better?
Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study  Christine Rønne.
Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar 
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Cystic fibrosis mortality trend in Italy from 1970 to 2011
Influence of digital clubbing on oxygen saturation measurements by pulse-oximetry in cystic fibrosis patients  Filip Van Ginderdeuren, Karlien Van Cauwelaert,
Vitamin A and lung function in CF
Nutritional status is associated with health-related quality of life in children with cystic fibrosis aged 9–19years  Suzanne M. Shoff, Audrey Tluczek,
Amyloidosis in cystic fibrosis: A case series
Spontaneous coronary artery dissection associated with coughing
Exercise-induced hypoxemia and cardiac arrhythmia in cystic fibrosis
A.H. Gifford  Journal of Cystic Fibrosis 
Initial evaluation of the Parent Cystic Fibrosis Questionnaire—Revised (CFQ-R) in infants and young children  Adrianne N. Alpern, Lyndia C. Brumback,
Tregony Simoneau, Gregory S. Sawicki, Carly E. Milliren, Henry A
Inhalation solutions — Which ones may be mixed
Physiologic endpoints for clinical studies for cystic fibrosis
Characterisation of mutations and genotype–phenotype correlation in cystic fibrosis: Experience from India  Shivaram S. Shastri, Madhulika Kabra, Sushil.
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?
Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis  Christopher R. Sudfeld, Elliott C. Dasenbrook, William.
Narelle S. Cox, Jennifer Follett, Karen O. McKay 
Gender differences in treatment adherence among youth with cystic fibrosis: Development of a new questionnaire  Joän M. Patterson, Melanie Wall, Jerica.
Respiratory pathogens mediate the association between lung function and temperature in cystic fibrosis  Joseph M. Collaco, Karen S. Raraigh, Lawrence.
Higher risk of hospitalization among females with cystic fibrosis
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
F. Vermeulen, P. Lebecque, K. De Boeck, T. Leal 
Successful treatment of cepacia syndrome with a combination of intravenous cyclosporin, antibiotics and oral corticosteroids  Francis J. Gilchrist, A.
V. Thompson, N. Mayer-Hamblett, M. Kloster, D. Bilton, P.A. Flume 
Determining presence of lung disease in young children with cystic fibrosis: Lung clearance index, oxygen saturation and cough frequency  E.M. Bakker,
Diabetes mellitus and survival in cystic fibrosis patients after lung transplantation  Markus Hofer, Christoph Schmid, Christian Benden, Rudolf Speich,
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis  Giuseppe Valenza, Dennis Tappe, Doris.
Daniel J. Smith, Gregory J. Anderson, Scott C. Bell, David W. Reid 
Michael W. Konstan, David J. Pasta, Jeffrey S. Wagener, Donald R
The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation  C. Etherington,
CFTR modulators and pregnancy: Our work has only just begun
‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis
L. Nshimyumukiza, A. Bois, P. Daigneault, L. Lands, A. -M. Laberge, D
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Exercise-induced hypoxemia and cardiac arrhythmia in cystic fibrosis
Patients with cystic fibrosis and normoglycemia exhibit diabetic glucose tolerance during pulmonary exacerbation  Noa Nezer M. Sc, David Shoseyov, Eitan.
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Presentation transcript:

The 1-min sit-to-stand test—A simple functional capacity test in cystic fibrosis?  Thomas Radtke, Milo A. Puhan, Helge Hebestreit, Susi Kriemler  Journal of Cystic Fibrosis  Volume 15, Issue 2, Pages 223-226 (March 2016) DOI: 10.1016/j.jcf.2015.08.006 Copyright © 2015 European Cystic Fibrosis Society. Terms and Conditions

Fig. 1 Boxplots showing median (25th, 75th percentiles) sit-to-stand (STS) repetitions from all STS tests during the pulmonary rehabilitation program. Significant differences were observed between STS0 and STS1 indicative of a learning effect (P<0.001). STS2a–2c were used to determine test–retest reliability. Journal of Cystic Fibrosis 2016 15, 223-226DOI: (10.1016/j.jcf.2015.08.006) Copyright © 2015 European Cystic Fibrosis Society. Terms and Conditions

Fig. 2 Correlations between mean sit-to-stand (STS) test repetitions (STS2a–2c) and measures of exercise capacity: (a) peak oxygen consumption (peakVO2), (b) maximum power, and (c) physical functioning scale of the revised Cystic Fibrosis Questionnaire (CFQ-R). Journal of Cystic Fibrosis 2016 15, 223-226DOI: (10.1016/j.jcf.2015.08.006) Copyright © 2015 European Cystic Fibrosis Society. Terms and Conditions